DarioHealth Corp. (NASDAQ:DRIO) Q4 2022 Results Conference Call March 9, 2023 8:30 PM ET Company Participants Glenn Garmont - Investor Relations Erez Raphael - Chief Executive Officer Rick Anderson - President Conference Call Participants Charles Rhyee - TD Cowen Alexander Nowak - Craig-Hallum Capital Group Rahul Rakhit - LifeSci Capital Ben Haynor - Alliance Global Partners David Grossman - Stifel Operator Greetings, and welcome to the DarioHealth Fourth Quarter 2022 Results Call. At this time, all partici ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ______________to________________ Commission File No. 001-37704 DARIOHEALTH CORP. (Exact name of registrant as specified in its charter) Delaware 45-2973162 (State or other ...

DarioHealth Corp. (NASDAQ:DRIO) Q3 2022 Results Conference Call November 15, 2022 8:30 AM ET Company Participants Glenn Garmont - IR Erez Raphael - CEO Rick Anderson - President Conference Call Participants Charles Rhyee – Cowen Rahul Rakhit - LifeSci Capital David Grossman – Stifel Ben Haynor - Alliance Global Partners Chase Knickerbocker - Craig-Hallum Operator Good day, everyone, and welcome to the DarioHealth Third Quarter 2022 Results Conference Call. [Operator Instructions] Please note, this event is ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 001-37704 DarioHealth Corp. | --- | --- | --- | |------------------------------------------------------------------- ...

DarioHealth Corp (NASDAQ:DRIO) Q2 2022 Earnings Conference Call August 15, 2022 8:30 AM ET Company Participants Glenn Garmont - LifeSci Advisors Erez Raphael - CEO & Director Richard Anderson - President & GM, North America Conference Call Participants Charles Rhyee - Cowen and Company Alexander Nowak - Craig-Hallum Rahul Rakhit - LifeSci Capital David Grossman - Stifel, Nicolaus & Company Benjamin Haynor - Alliance Global Partners Nathan Weinstein - Aegis Capital Corporation John Vandermosten - Zacks Small ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 001-37704 | --- | --- | |------------------------------------------------------------------------------------------------ ...

DarioHealth Corp. (NASDAQ:DRIO) Q1 2022 Earnings Conference Call May 12, 2022 8:30 AM ET Company Participants Glenn Garmont - Investor Relations Erez Raphael - Chief Executive Officer Rick Anderson - President & General Manager, North America Conference Call Participants Charles Rhyee - Cowen Rahul Rakhit - LifeSci Capital Nathan Weinstein - Aegis Capital John Vandermosten - Zacks David Grossman - Stifel Operator Good morning and welcome to the DarioHealth First Quarter 2022 Results Call. all participants w ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 001-37704 | --- | --- | |----------------------------------------------------------------------------------------------- ...

DarioHealth Corp. (NASDAQ:DRIO) Q4 2021 Earnings Conference Call March 22, 2022 8:30 AM ET Company Participants Glenn Garmont – Investor Relations Erez Raphael – Chief Executive Officer Rick Anderson – President and General Manager-North America Zvi Ben-David – Chief Financial Officer Conference Call Participants Alex Nowak – Craig Hallam Craig Jones – Stifel Operator Greetings, and welcome to the DarioHealth Corporation Fourth Quarter 2021 Results Conference Call. At this time all participants are in a lis ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ______________to________________ Commission File No. 001-37704 DARIOHEALTH CORP. (Exact name of registrant as specified in its charter) Delaware 45-297316 ...